Development of antibody-based c-Met inhibitors for targeted cancer therapy

Development of antibody-based c-Met inhibitors for targeted cancer therapy

Dongheon Lee, Eun-Sil Sung, Jin-Hyung Ahn, Sungwon An, Jiwon Huh, Weon-Kyoo You Hanwha Chemical R&D Center, Biologics Business Unit, Daejeon, Republic of Korea Abstract: Signaling pathways mediated by receptor tyrosine kinases (RTKs) and their ligands play important roles in the development...

Full description

Bibliographic Details
Main Authors:	Lee D, Sung ES, Ahn JH, An S, Huh J, You WK
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-02-01
Series:	ImmunoTargets and Therapy
Subjects:	Hepatocyte growth factor Ligands Receptor tyrosine kinase Signaling pathway Therapeutic agent
Online Access:	https://www.dovepress.com/development-of-antibody-based-c-met-inhibitors-for-targeted-cancer-the-peer-reviewed-article-ITT

Similar Items

Control of cell death/survival balance by the MET dependence receptor
by: Leslie Duplaquet, et al.
Published: (2020-02-01)

Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer
by: Chen-Yu Hu, et al.
Published: (2019-12-01)

Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody
by: Jianqun Kou, et al.
Published: (2018-09-01)

Role of Met Axis in Head and Neck Cancer
by: Yiru Xu, et al.
Published: (2013-11-01)

Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
by: D. Samuel Metibemu, et al.
Published: (2019-12-01)

Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
by: Kalpana K. Bhanumathy, et al.
Published: (2021-01-01)

Identification of Eph receptor signaling as a regulator of autophagy and a therapeutic target in colorectal carcinoma
by: Michael DiPrima, et al.
Published: (2019-11-01)

The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer Models
by: Friedhelm Bladt, et al.
Published: (2014-08-01)

Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors
by: Wagner Ricardo Montor, et al.
Published: (2018-02-01)

AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
by: Chenjing Zhu, et al.
Published: (2019-11-01)

The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer
by: Oana-Stefana Purcaru, et al.
Published: (2021-05-01)

Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products
by: Kodappully S. Siveen, et al.
Published: (2018-02-01)

Physiological Signaling and Structure of the HGF Receptor MET
by: Gianluca Baldanzi, et al.
Published: (2014-12-01)

Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma
by: Lucia Demkova, et al.
Published: (2018-02-01)

Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer
by: Mai Tanaka, et al.
Published: (2021-09-01)

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular features as drug targets and antibody-drug conjugates for therapy
by: Hang-Ping Yao, et al.
Published: (2020-09-01)

Activated HGF-c-Met Axis in Head and Neck Cancer
by: Levi Arnold, et al.
Published: (2017-12-01)

Targeting Bruton’s Tyrosine Kinase in CLL
by: Inhye E. Ahn, et al.
Published: (2021-06-01)

Phage-Displayed Peptides for Targeting Tyrosine Kinase Membrane Receptors in Cancer Therapy
by: Annamaria Aloisio, et al.
Published: (2021-04-01)

Registered report: Widespread potential for growth factor-driven resistance to anticancer kinase inhibitors
by: Edward Greenfield, et al.
Published: (2014-12-01)

MET in glioma: signaling pathways and targeted therapies
by: Fangling Cheng, et al.
Published: (2019-06-01)

HGF/SF Increases Tumor Blood Volume: A Novel Tool for the In Vivo Functional Molecular Imaging of Met
by: Galia Tsarfaty, et al.
Published: (2006-05-01)

Receptor tyrosine kinases and schistosome reproduction: new targets for chemotherapy
by: Marion eMorel, et al.
Published: (2014-07-01)

HGF/Met Axis in Heart Function and Cardioprotection
by: Simona Gallo, et al.
Published: (2014-10-01)

Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
by: Mohammad Hojjat-Farsangi
Published: (2014-08-01)

Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?
by: Lorenzo-Vizcaya A, et al.
Published: (2020-06-01)

Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance
by: Marcia N. Paddock, et al.
Published: (2019-04-01)

Regulation of the TCR signaling pathway
by: Rivera Reyes, Brenda Mariola
Published: (2006)

Quantitative Phosphoproteomics Reveals System-Wide Phosphorylation Network Altered by Spry in Mouse Mammary Stromal Fibroblasts
by: Tiezhu Shi, et al.
Published: (2019-10-01)

Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme
by: Manali Tilak, et al.
Published: (2021-02-01)

The Emerging Role of TYRO3 as a Therapeutic Target in Cancer
by: Sherri K. Smart, et al.
Published: (2018-11-01)

Ligand-induced downregulation of the kinase-dead EphB6 receptor
Published: (2015)

PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models
by: Lluís Nisa, et al.
Published: (2017-05-01)

TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
by: Yixuan Liu, et al.
Published: (2021-10-01)

Novel Peptide CM 7 Targeted c-Met with Antitumor Activity
by: Chunlei Xia, et al.
Published: (2020-01-01)

Identification of Inhibitors of Integrin Cytoplasmic Domain Interactions With Syk
by: Deenadayalan Bakthavatsalam, et al.
Published: (2021-01-01)

WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer
by: Shuai Chen, et al.
Published: (2017-07-01)

Identification of Phospho-Tyrosine Targets as a Strategy for the Treatment of Esophageal Adenocarcinoma Cells
by: Lee J, et al.
Published: (2021-06-01)

Receptor tyrosine kinases as a therapeutic target by natural compounds in cancer treatment
by: Toheeb A. Balogun, et al.
Published: (2021-10-01)

Stepwise participation of HGF/MET signaling in the development of migratory muscle precursors during vertebrate evolution
by: Noritaka Adachi, et al.
Published: (2018-06-01)